ARCHIVES

Guest Editorial: Even Slam-Dunk Applications Can Benefit From Public Scrutiny and Discussion at ODAC

This article is from The Cancer Letter archive.

Vol. 38 No. 32 | August 10, 2012

Download PDF Visit The Full Archive

Related Articles

FDA News: Tentative Approval Given IVAX Paxene; BMS Exclusivity Upheld

January 9, 1998

In Brief: Stetten’s Deputy, Von Euler, Takes Over At NIGMS; Sherman’s Replacement Probably Will Be In-House

March 15, 1974

Excerpts From A Confidential Report Detailing the I-ELCAP Study’s Design Flaws and Lack of Consent

April 29, 2011

Chabner, FDA’s Temple continue disagreement Over Drug Approval

February 10, 1989

Statin Drugs May Prevent Breast Cancer, Lab Suggests

April 25, 2003

DCBDC To Contract For CA Agents In Vaccine Testing

November 15, 1991